Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1380 participants.

Also called NCT07397845

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,380 participants (planned count) (from the registry)
Sponsor
Translumina GmbH (from the registry)
Registry
  • NCT NCT07397845
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07397845. Randomized; no masking; primary purpose treatment. Start 2026-04-22 (actual); primary completion 2028-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Stents Versus PAclitaxel Coated Balloons for Revascularization of CompleX and Small Coronary Vessels (SPARX) Trial
Acronym
SPARX RCT
Condition
Drug Eluting Balloon
Condition
Drug Eluting Stent
Intervention (Device)
Protégé and Protégé NC
Intervention (Device)
Agent
Intervention (Device)
Drug Eluting Stent
Lead sponsor
Translumina GmbH (class: industry)

Record details

Record id
cardio:ct-nct07397845
Content hash
f8fe537e4327dd44ee0e0d510edf16e6308f23604874e07e0e3f1040aebdd502